Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01532596 · ClinicalTrials.gov registry record · Early Phase 1

Mindfulness Meditation in Older Adults

A Early Phase 1 study of Aging, sponsored by University of California, Los Angeles.

Completed
Registry status
Early Phase 1
Development phase
40
Enrollment target
1
Study location

NCT01532596 is a Early Phase 1 study of Aging that has completed, run by University of California, Los Angeles. The registered enrollment target is 40 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01532596, a Early Phase 1 study of Aging, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Early Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test if an 8-week mindfulness meditation training (vs a wait-list control condition) program reduces neurobehavioral reactivity and improves affect regulation in a sample of older adults, as measured by functional magnetic resonance imaging. Additionally, we will examine if mindfulness meditation training reduces loneliness and markers of chronic inflammation.

Conditions Studied

Interventions

  • BEHAVIORAL Mindfulness-Based Stress Reduction

Study Locations (1)

California

  • Cousins Center for Psychoneuroimmunology, UCLA - Los Angeles

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2008-01
Est. Completion 2009-01
Phase Early Phase 1

What the Registry Record Tells You About NCT01532596

The ClinicalTrials.gov registry entry for NCT01532596 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness-Based Stress Reduction is the first listed.

NCT01532596 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01532596 about?

NCT01532596 is a clinical study titled "Mindfulness Meditation in Older Adults". The purpose of this study is to test if an 8-week mindfulness meditation training (vs a wait-list control condition) program reduces neurobehavioral reactivity and improves affect regulation in a sample of older adults, as measured by functional magnetic resonance imaging. Additionally, we will exam...

What is the current status of trial NCT01532596?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2008-01. Estimated completion is 2009-01.

What conditions does trial NCT01532596 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT01532596?

The interventions under investigation include: Mindfulness-Based Stress Reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT01532596?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01532596 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.